DWP14012: Clinical Trials

2 trials of DWP14012, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow DWP14012: new trials by email Literature Review of DWP14012 trials Research Report on DWP14012

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
Fexuprazan, Esomeprazole - Gastro Oesophageal Reflux Disease
Phase 3CompletedUniversitas Indonesia1452024-08-282026-08-24
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
DWP14012 - Reflux Esophagitis
Phase 3CompletedDaewoong Pharmaceutical Co. LTD.3322021-12-302023-04-14

Conditions studied

Esophagitis, Peptic (1)  ·  Gastroesophageal Reflux (1)

Sponsors

Daewoong Pharmaceutical Co. LTD. (1)  ·  Universitas Indonesia (1)

Countries

China (1)  ·  Indonesia (1)

Top investigators

Ari Fahrial Syam, MD, PhD (1)

Results publications

PMID 38251791